In another example, miR-142-5p targeted several antiapoptotic genes, including baculoviral IAP repeat-containing 3 (BIRC3), B-cell lymphoma-2 (BCL2), BCL2-like 2 (BCL2L2), and myeloid cell leukemia sequence 1 (MCL1), and could improve cisplatin-mediated anticancer function in ovarian cancer [39]. Here, BCL2L2 is linked to ovarian carcinoma.